REDCARE PHARMACY NV (RDC.DE) Stock Overview
Europe - FRA:RDC - NL0012044747 - Common Stock
RDC.DE Key Statistics, Chart & Performance
The current stock price of RDC.DE is 74.45 EUR. In the past month the price decreased by -19.69%. In the past year, price decreased by -39.03%.
RDC.DE Competitors/Peers
Related stock screener links
About RDC.DE
Company Profile
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. The company is headquartered in Sevenum, Limburg and currently employs 2,659 full-time employees. The company went IPO on 2016-10-13. The firm focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The firm is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Company Info
REDCARE PHARMACY NV
Erik de Rodeweg 11/13
Sevenum LIMBURG NL
Employees: 2659
REDCARE PHARMACY NV / RDC.DE FAQ
What is the stock price of REDCARE PHARMACY NV today?
The current stock price of RDC.DE is 74.45 EUR. The price increased by 1.85% in the last trading session.
What is the ticker symbol for REDCARE PHARMACY NV stock?
The exchange symbol of REDCARE PHARMACY NV is RDC and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is RDC.DE stock listed?
RDC.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for REDCARE PHARMACY NV stock?
14 analysts have analysed RDC.DE and the average price target is 157.08 EUR. This implies a price increase of 110.99% is expected in the next year compared to the current price of 74.45. Check the REDCARE PHARMACY NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is REDCARE PHARMACY NV worth?
REDCARE PHARMACY NV (RDC.DE) has a market capitalization of 1.51B EUR. This makes RDC.DE a Small Cap stock.
How many employees does REDCARE PHARMACY NV have?
REDCARE PHARMACY NV (RDC.DE) currently has 2659 employees.
What are the support and resistance levels for REDCARE PHARMACY NV (RDC.DE) stock?
REDCARE PHARMACY NV (RDC.DE) has a support level at 72.5 and a resistance level at 76.05. Check the full technical report for a detailed analysis of RDC.DE support and resistance levels.
Is REDCARE PHARMACY NV (RDC.DE) expected to grow?
The Revenue of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 25.66% in the next year. Check the estimates tab for more information on the RDC.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy REDCARE PHARMACY NV (RDC.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RDC.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RDC.DE, evaluating the profitability, health, valuation and growth aspects
- REDCARE PHARMACY NV (RDC.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- REDCARE PHARMACY NV (RDC.DE) Sales and EPS estimates to see what analysts future expectations are.
- REDCARE PHARMACY NV (RDC.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- REDCARE PHARMACY NV (RDC.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- REDCARE PHARMACY NV (RDC.DE) Stock Chart to make your own analysis
- REDCARE PHARMACY NV (RDC.DE) Latest news and press-releases to stay up to date.
Does REDCARE PHARMACY NV (RDC.DE) stock pay dividends?
RDC.DE does not pay a dividend.
When does REDCARE PHARMACY NV (RDC.DE) report earnings?
REDCARE PHARMACY NV (RDC.DE) will report earnings on 2025-10-29.
What is the Price/Earnings (PE) ratio of REDCARE PHARMACY NV (RDC.DE)?
REDCARE PHARMACY NV (RDC.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.74).
RDC.DE Technical Analysis
RDC.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE. RDC.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
RDC.DE Financial Highlights
Over the last trailing twelve months RDC.DE reported a non-GAAP Earnings per Share(EPS) of -1.74. The EPS decreased by -201.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.81% | ||
| ROE | -6.85% | ||
| Debt/Equity | 0.61 |
RDC.DE Forecast & Estimates
14 analysts have analysed RDC.DE and the average price target is 157.08 EUR. This implies a price increase of 110.99% is expected in the next year compared to the current price of 74.45.
For the next year, analysts expect an EPS growth of 47.93% and a revenue growth 25.66% for RDC.DE